AstraZeneca (AZNCF) Stock Price, News & Analysis

Company Overview

AstraZeneca plc is a global biopharmaceutical company headquartered in Cambridge, United Kingdom. The company discovers, develops and commercializes prescription medicines, with a focus on scientific innovation and treatments for serious and chronic diseases.

Its principal therapeutic areas include oncology, cardiovascular, renal and metabolic diseases, respiratory and immunological conditions, rare diseases, and vaccines and immune therapies. AstraZeneca’s portfolio includes medicines such as Tagrisso, Imfinzi, Lynparza, Farxiga, Symbicort, Fasenra and Ultomiris, among other prescription treatments.

AstraZeneca was formed in 1999 through the merger of Sweden’s Astra AB and the United Kingdom’s Zeneca Group. The company serves patients and healthcare systems internationally, with research, development, manufacturing and commercial operations across major markets in North America, Europe, Asia and other regions. Pascal Soriot has served as the company’s chief executive officer.

Key Stats

• Today's Range: $183.90 to $187.10
• 50-Day Range: $187.10 to $187.10
• 52-Week Range: $122.26 to $195.00
• Volume: N/A
• Average Volume: 1,957 shs
• Market Capitalization: N/A
• P/E Ratio: 229.29
• Dividend Yield: 1.50%
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:AZNCF
• CIK: 901832
• Web: www.astrazeneca.com
• Phone: 442037495000
• Fax: N/A
• Employees: 83,500
• Year Founded: 1913

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 229.29
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A